Navigation Links
Painful condition affecting kidney failure patients increases risk of death
Date:9/27/2007

maging studies should first have their kidney function checked, and gadolinium-containing contrast should not be used in those with significant underlying kidney disease. More information is needed to determine the risk for those with milder forms of kidney disease. The study was conducted by Todd and co-author Anna Kagan, MD, PhD, while they were medical residents at MGH. Lori B. Chibnik of Brigham and Womens Hospital was the studys biostatician.


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Healing a painful neck
2. Spine Surgeries becoming less painful
3. Self Hypnotic Relaxation Makes Breast Biopsy Easier and Less Painful
4. Knee Osteoarthritis More Painful for Smokers: Study
5. New, Less Painful Wound Treatment for Pediatric Patients
6. A Fresh Alternative to Painful Chemotherapy Developed in UK
7. New Cancer Therapy That can Be Less Painful
8. New, Less Painful Wound Treatment for Pediatric Patients
9. Lethal Heart Condition linked To Cocaine Use
10. Ultrasound test may detect heart condition early
11. Gastrointestinal conditions affect sleep
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008)... The Accreditation Council ...ed the Education Division of the College of Americ...with Commendation as a provider of continuing medi... Northfield, IL (PRWEB) August 28, 2008 -- T...ucation (ACCME) has awarded the Education Division...
(Date:8/28/2008)... Popular Chef and March of Dimes Volunteer to tak...AINS, N.Y., Aug. 28 /PRNewswire-USNewswire/ -- Fro...n "Rock" Harper will be making the,rounds at ten M...public,nationwide this fall., Chef Rock is the Ma...erson. In this role, Chef Rock, winner of Fox Tele...
(Date:8/27/2008)... Thousands of medical students will gain access t...ng through REACHMD XM 157, the first satellite, ra...edical professionals., CHICAGO, Aug. 27 /PRNewswi...gic programming partnership with the American Medi...t and largest, independent,association for physici...
(Date:8/27/2008)...nding could lead to new drugs in fight against obe...(HealthDay News) -- A chemical produced in the bra...likelihood of becoming obese, according to a new s... group of 33 people who had WAGR syndrome, a genet...llion people. WAGR is an acronym for the symptoms ...
Breaking Medicine News(10 mins):Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3Health News:Chef Rock to Rock Signature Chefs Auctions(R) Nationwide 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 3Health News:Low Levels of Brain Chemical May Control Appetite 2
...ulation shows that bone health is set to become a ...ods market. The lifetime risk for a woman to have ...in men the risk is about 13 per cent. Yet the main...m supplements are entering a mature category, and ...
...sity) is most common in older adults, particularly...es that will become a bigger and more costly probl...vitamin D has been shown to reduce the risk of fra... regarding how much of Vitamin D is needed has to ...
... of Human Organ Act was passed in India, we have n...been due to various reasons. //First and foremost ...ly consider this as an alternative to living organ...tiative from the Government after the act was pass...
...raise the level of inflammatory makers that influe...ublished by Archives of Neurology. Conditions of i...ated with elevated levels //of inflammatory marker...disease (AD). Inflammation has been proposed as a ...
Other Medicine News:Health News:The Potential Of Cadaver Transplantation Programme In India 2Health News:The Potential Of Cadaver Transplantation Programme In India 3
(Date:8/25/2008)...TEO, Calif., Aug. 25 /- Anthera Pharm...l company developing,anti-inflammatory drugs, toda...ecurrent Acute coronary events with Near-term Card...l designed to examine the impact of,varespladib wh...Acute,Coronary Syndrome (ACS) event., The FRANCIS...
(Date:8/22/2008)...Women Enrolled in Trial Sponsored by Medical Resea...e-FirstCall/ -- Indevus,Pharmaceuticals, Inc. (Nas...ollment in Protocol MDP 301, a Phase III clinical ... microbicide for the prevention of HIV and other,s...ored by the United,Kingdom,s Medical Research Coun...
(Date:8/22/2008)...LLE, Md., Aug. 22 /- Human ...nced that it has completed the,enrollment and init...al of,HGS-ETR1 (mapatumumab) in combination with t...as first-line therapy in advanced non-small cell,l...om/cgi-bin/prnh/20080416/HGSLOGO ), "There is an...
(Date:8/21/2008)...TAN, Kan., Aug. 21 /PRNewswire-USNewswire/ -- A re...oli O157:H7 expert T.G. Nagaraja has,been tapped b... the,connection between feeding distillers, grains...ies to reduce the presence of the naturally occurr...ved a $939,220 National Research Initiative in Foo...
Breaking Medicine Technology:Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers' Grains 2Blood test takes step toward predicting Alzheimers risk Stanford researchers find 3623 1Blood test takes step toward predicting Alzheimers risk Stanford researchers find 3623 2Blood test takes step toward predicting Alzheimers risk Stanford researchers find 3623 3Blood test takes step toward predicting Alzheimers risk Stanford researchers find 3623 4Study reveals a key to blood vessel growth and possible drug target 794 1Study reveals a key to blood vessel growth and possible drug target 794 2Study reveals a key to blood vessel growth and possible drug target 794 3U S Unveils Database of Genetic Clinical Research 3620 1U S Unveils Database of Genetic Clinical Research 3620 2Governor Rendells Tour to Insure Urges Passage of Plan to Give Access to Affordable Health Insurance 3617 1Governor Rendells Tour to Insure Urges Passage of Plan to Give Access to Affordable Health Insurance 3617 2Governor Rendells Tour to Insure Urges Passage of Plan to Give Access to Affordable Health Insurance 3617 3
...s should find these data reassuring", PHILADELPHIA...thKline said today that findings from an interim a...diac Outcomes and,Regulation of glycemia in Diabet...cally to determine cardiovascular outcomes in more...rther evidence to,the overall cardiovascular safet...
...E)--Jun 5, 2007 - ERBITUX (cetuximab), the,first a...dermal,growth factor receptor (EGFR) developed and...as the focus of nine oral and 46,poster presentati...of the American Society of Clinical Oncology (ASCO...ed the extensive,clinical development of ERBITUX r...
Other Medicine Technology:Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 2Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 3Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 4Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 5Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 2Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 3Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 4Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 5Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 6Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 7Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 8Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 9Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 10
For proper plug sizing.
Skin Tone External Eyelid Weights
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea.
For Frontalis Suspension in patients with significant ptosis and poor levator function.
Medicine Products: